Press Releases S2Medical AB

Equities

S2M

SE0011725084

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
0.0435 ^SEK	+3.57%		-7.45%	-27.50%

May. 17	S2Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 20	S2Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Epiprotect® Demonstrates Significantly Lower Infection Risk in Major Pediatric Study	Jun. 20	AQ
S2Medical AB (publ) Signs Exclusive Distribution Agreement with Provas Medical Ltd for the Turkish Market	Nov. 06	AQ
INTERIM REPORT APRIL - JUNE 2023	23-08-25	AQ
S2Medical AB (publ) announces final outcome in the company's rights issue	23-07-05	AQ
S2Medical AB Secures New Loan Agreement and Aims to be Debt-Free by July 2024	23-07-04	AQ
S2Medical (publ) announces preliminary outcome in the company's rights issue	23-07-03	AQ
S2Medical AB (publ) publishes a prospectus regarding the rights issue	23-06-16	AQ
S2Medical AB (publ) signs a manufacturing agreement with a distributor in Saudi Arabia	23-06-08	AQ
S2Medical AB (publ) signs a distribution agreement for the Iranian market	23-05-17	AQ
S2Medical wins procurement for wound healing items in the Västra Götaland region	23-05-16	AQ
Postponing of publication of the quarterly report for the period January to March 2023	23-05-10	AQ
Postponement of publication of annual report	23-04-24	AQ
S2Medical wins procurement for wound healing items in the United Arab Emirates worth approximately SEK 3.4 million	23-04-21	AQ
S2Medical AB (publ) signs a distributor agreement in the United Arab Emirates and delivers a record order of the skin substitute Epiprotect worth about SEK 2 million	23-04-13	AQ
S2Medical implements a strategic change to reach profitability faster	23-03-28	AQ
S2Medical wins procurement for wound healing equipment in Region Halland	23-03-03	AQ
Year-end report January - December 2022 S2Medical AB (publ)	23-02-22	AQ
Postponing of publication of the year-end report	23-02-16	AQ
Positive outcome when S2Medicals antimicrobial peptides were tested against the multi resistant bacteria that by WHO have been defined as a global health threat	23-01-02	AQ
Epiprotect reduces the cost for treatment of hard to heal leg ulcers with 83%	22-12-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases S2Medical AB

Equities

S2M

SE0011725084

Press Releases

Filters